Connor, Clark & Lunn Investment Management (CC&L)
MRVI icon

Connor, Clark & Lunn Investment Management (CC&L)’s Maravai LifeSciences MRVI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-316,502
Closed -$699K – 1617
2025
Q1 		$699K Sell
316,502
-131,492
-29% -$520K ﹤0.01% 1057
2024
Q4 		$2.44M Buy
447,994
+57,727
+15% +$371K 0.01% 669
2024
Q3 		$3.24M Sell
390,267
-60,195
-13% -$520K 0.02% 548
2024
Q2 		$3.23M Buy
450,462
+112,038
+33% +$967K 0.01% 536
2024
Q1 		$2.93M Buy
+338,424
New +$2.29M 0.01% 563

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MRVI Position: Q2 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 316,502 shares — an estimated $699K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MRVI in Q1 2024 and held it in 5 quarters. The position peaked at $3.24M in Q3 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 316,502 Maravai LifeSciences shares in Q2 2025, an estimated $699K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Maravai LifeSciences in Q1 2024 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Maravai LifeSciences position peaked at $3.24M in Q3 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.